We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$134M
Cap. Flow
+$20.8M
Cap. Flow %
0.9%
Top 10 Hldgs %
37.03%
Holding
3,655
New
192
Increased
1,156
Reduced
1,283
Closed
307
Avg Time Held Equity + Options
3.3 years
Top 10 Avg Time Held Equity + Options
2.3 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.4 years
Top 10 Avg Time Held Equity only
2.3 years
Top 20 Avg Time Held Equity only
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.63%
2 Technology 11.72%
3 Healthcare 8.76%
4 Financials 8.75%
5 Consumer Discretionary 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AVTX icon
3276
Avalo Therapeutics
AVTX
$644M
– –
0
– –
2020 Q1
11 quarters
DCTH icon
3277
Delcath Systems
DCTH
$514M
$4 ﹤0.01%
1
– –
2020 Q2
10 quarters
IMUX icon
3278
Immunic
IMUX
$96.9M
– –
0
– –
2018 Q2
18 quarters
WINT icon
3279
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
2020 Q2
10 quarters
HEXO
3280
DELISTED
HEXO Corp. Common Shares
HEXO
$2 ﹤0.01%
2
– –
2019 Q2
14 quarters
VLTA
3281
DELISTED
Volta Inc.
VLTA
$2 ﹤0.01%
6
-650
-99% -$493
2020 Q4
8 quarters
GET
3282
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$2 ﹤0.01%
1
– –
2022 Q1
3 quarters
BTBT icon
3283
Bit Digital
BTBT
$389M
– –
-1
Closed -$1 –
AADR icon
3284
AdvisorShares Dorsey Wright ADR ETF
AADR
$35.9M
– –
-483
Closed -$21K –
ABG icon
3285
Asbury Automotive
ABG
$3.05B
– –
-4
Closed -$1K –
ADCT icon
3286
ADC Therapeutics
ADCT
$190M
– –
-10
Closed -$40 –
ADTN icon
3287
Adtran
ADTN
$532M
– –
-14
Closed – –
ADV icon
3288
Advantage Solutions
ADV
$376M
– –
-6
Closed – –
AGIO icon
3289
Agios Pharmaceuticals
AGIO
$1.93B
– –
-4
Closed – –
AHCO icon
3290
AdaptHealth
AHCO
$852M
– –
-6
Closed – –
AIRR icon
3291
First Trust RBA American Industrial Renaissance ETF
AIRR
$8.67B
– –
-1,564
Closed -$60K –
AKR icon
3292
Acadia Realty Trust
AKR
$2.54B
– –
-133
Closed -$2K –
AMAL icon
3293
Amalgamated Financial
AMAL
$1.41B
– –
-78
Closed -$2K –
AMRX icon
3294
Amneal Pharmaceuticals
AMRX
$6.7B
– –
-60
Closed – –
AMSF icon
3295
AMERISAFE
AMSF
$464M
– –
-134
Closed -$6K –
AOD icon
3296
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
– –
-250
Closed -$2K –
AQN icon
3297
Algonquin Power & Utilities
AQN
$4B
– –
-31
Closed – –
ARCT icon
3298
Arcturus Therapeutics
ARCT
$320M
– –
-17
Closed -$296 –
ARKO icon
3299
ARKO Corp
ARKO
$461M
– –
-191
Closed -$2K –
ARKX icon
3300
ARK Space & Defense Innovation ETF
ARKX
$717M
– –
-150
Closed -$2K –

Similar funds

Parallel Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Parallel Advisors held 3,655 positions worth $2.31B, up 6.1% from $2.17B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2022 filing shows 192 new, 1,156 increased, 1,283 reduced and 307 closed positions. Its largest new stake was US Treasury 2 Year Note ETF: 9,020 shares worth $440K. The largest sale was iShares Core MSCI EAFE ETF, an estimated $15.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q4 2022 buy was US Treasury 2 Year Note ETF: 9,020 shares worth $440K.
  • Parallel Advisors added most to Schwab US Dividend Equity ETF in Q4 2022, an estimated $38.6M increase.
  • Parallel Advisors's biggest Q4 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $15.8M.
  • Parallel Advisors fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.3M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.31B portfolio in Q4 2022.
  • Parallel Advisors opened 192 new positions and closed 307 in Q4 2022.
  • Parallel Advisors's portfolio value rose 6.1% quarter-over-quarter to $2.31B.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.